Mental Health News
Stay updated on mental health with press releases highlighting trends, treatments, and advocacy efforts addressing mental well-being. Learn about key developments shaping mental health and explore opportunities in psychological research and therapy innovations.
May 22, 2026 at 12:57 PM
CFX and Fitness for Recovery Announce Partnership to Support Recovery Community
CHICAGO--(BUSINESS WIRE)--CFX, a Chicago-based, family-owned fitness brand with 17 locations, is proud to announce a new partnership with Fitness for Recovery, a nonprofit organization dedicated to helping individuals in recovery from substance use disorder through fitness and offering discounted memberships to any individuals in recovery. The partnership will launch at CFX's Crest Hill location, where Fitness for Recovery participants will have access to CFX clubs, amenities, and group trainin...
May 22, 2026 at 7:30 AM
Boys & Girls Clubs of America Expands Trauma-Informed Approach to Advance Youth Mental Wellness Nationwide
ATLANTA--(BUSINESS WIRE)--As conversations around mental health take center stage this May, Boys & Girls Clubs of America is strengthening its commitment to youth mental wellness through expanded trauma‑informed practices across its nationwide network. The effort ensures more young people have access to trusted adults, safe environments, and the critical supports they need to thrive. Serving more than 4 million youth annually through over 5,500 Club sites, Boys & Girls Clubs meet young...
May 21, 2026 at 11:00 AM
The Mental Health Symptoms Patients Most Often Miss: Serenity Mental Health Centers Releases 2024 Outcomes Data for Mental Health Awareness Month
ATLANTA--(BUSINESS WIRE)--Mental Health Awareness Month arrives this year amid growing evidence that millions of Americans living with depression, anxiety and post-traumatic stress disorder (PTSD) recognize their symptoms long after they first appear. Serenity Mental Health Centers, an outpatient mental health clinic network with more than 35 clinics across the United States, today released 2024 patient outcomes data and clinical guidance from its Chief Medical Officer to help patients, familie...
May 21, 2026 at 7:00 AM
Alkermes Showcases Data From Psychiatry Portfolio and Sleep Research into Real World Patient Experience at Spring 2026 Scientific Conferences
DUBLIN--(BUSINESS WIRE)--Alkermes plc (Nasdaq: ALKS) today announced the presentation of accepted research at key scientific conferences this spring related to its psychiatry products—LYBALVI® (olanzapine and samidorphan) and ARISTADA® (aripiprazole lauroxil)—and its ongoing involvement in sleep medicine. The data presented reflect Alkermes’ ongoing commitment to contributing to the advancement of patient care and expanding the body of evidence in neuroscience. The meetings included: The Psych...
May 21, 2026 at 7:00 AM
Baszucki Group Funds Oxford University Clinical Trial of Ketogenic Therapy for Early Psychosis
SAN MATEO, Calif.--(BUSINESS WIRE)--Baszucki Group announce funding to support University of Oxford randomized controlled trial of ketogenic therapy for early psychosis....
May 20, 2026 at 9:00 AM
New Headspace Report Shows America’s Workers Are Running on Empty, and It’s Getting Worse
SAN FRANCISCO--(BUSINESS WIRE)--Headspace, the leading mental health companion for everyday support, today released its eighth annual Workforce State of Mind report, with data pointing to an emerging chronic strain crisis across the workforce stemming from the slow, relentless accumulation of mental and cognitive pressure that never fully powers down. With 92% of workers experiencing strain, these pressures have quietly intensified. About 37% of workers say that strain has increased in the past...
May 20, 2026 at 8:00 AM
Autobahn Therapeutics Presents New Preclinical Data at ASCP Annual Meeting Demonstrating Elunetirom Drives Robust Bioenergetic and Neuroplastic Improvements in Neuronal Cultures
SAN DIEGO--(BUSINESS WIRE)--Autobahn Therapeutics, Inc., a biotechnology company developing restorative treatments for people affected by neuropsychiatric disorders, today announced the presentation of new preclinical data for elunetirom (ABX-002), the company’s lead asset currently in Phase 2 clinical development for adjunctive major depressive disorder (MDD) and bipolar depression, at the 2026 American Society of Clinical Psychopharmacology (ASCP) Annual Meeting taking place in Miami Beach, F...
May 20, 2026 at 8:00 AM
The Foundation for the National Institutes of Health Announces Recipients of the Deeda Blair Research Initiative for Disorders of the Brain
NORTH BETHESDA, Md.--(BUSINESS WIRE)--The FNIH announces three new recipients of awards from the Deeda Blair Research Initiative for Disorders of the Brain....
May 19, 2026 at 9:00 AM
NaphCare and NaphCare Charitable Foundation Launch Third Annual "Reframing Mental Health" Art Initiative
BIRMINGHAM, Ala.--(BUSINESS WIRE)--As part of Mental Health Awareness Month, NaphCare, a leading correctional healthcare company, and the NaphCare Charitable Foundation (NCF) highlight the third year of their annual art initiative and advocacy campaign, “Reframing Mental Health.” Original artwork created by patients at 12 NaphCare partner facilities across eight states will be exhibited in May to mark Mental Health Awareness Month. Nearly two in five people in correctional facilities experience...
May 19, 2026 at 8:00 AM
LivaNova to Present at Goldman Sachs Global Healthcare Conference in June
LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, Fla. Vladimir Makatsaria, Chief Executive Officer of LivaNova; Alex Shvartsburg, Chief Financial Officer; and Phil Kowalczyk, Chief Strategy and Corporate Development Officer, will participate in a fireside chat on Mon., June 8, 2026, at 8 a.m. Eastern Daylight Time. The discussion will be...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.